Research
This Fortnight in Medicine XXXVIII
Sensible Medicine · By Adam Cifu & MD ·
The Brief
- The newsletter revisits discontinuing statins in older adults without cardiovascular disease, following up on an earlier fortnight discussion of a statin discontinuation trial.
- It also covers pelacarsen and cardiovascular outcomes in patients with high lipoprotein(a).
- The source is a newsletter roundup and gives no further trial results or figures.
Why it matters
Whether older adults without cardiovascular disease should stay on statins bears directly on prescribing decisions, and the source points to ongoing trial evidence on this question.
Who’s affected
- clinicians who prescribe statins to older adults
- older adults taking statins for primary prevention
Discontinuing Statins in Older Adults without Cardiovascular Disease Fortnight 33 , on which we discussed the last statin discontinuation trial. Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)